Innovations in Heart Failure: Highlights and Insights From AHA 2021 *

November 13-15, 2021; Virtual
Review the latest data on managing heart failure with Capsule Summaries and expert-authored commentaries covering key studies from AHA 2021.

Share

Program Content

Activities

Canagliflozin HF Symptoms
CHIEF-HF: Improvement in Heart Failure Symptoms at 12 Wk With Canagliflozin vs Placebo
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 03, 2021

Expires: December 02, 2022

HF Early Relapse Detection
Cardiac Imaging Key to Detecting Early Relapse After Withdrawal of Heart Failure Medications in Patients In Remission
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 02, 2021

Expires: December 01, 2022

Empagliflozin LVEF ≥50%
EMPEROR-Preserved: Primary Endpoint and Key Quality of Life Results With Empagliflozin vs Placebo in Patients With LVEF ≥50%
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 02, 2021

Expires: December 01, 2022

Activities

New Data in HF

“A-ha” Moments From AHA 2021: My Take on New Data in Heart Failure

Clinical Thought
Conference Coverage
Congratulations: You achieved a completion on 04/09/2022

Released: December 08, 2021

Expires: December 07, 2022

AHA 2021: Novel Therapies
Novel Therapies Affecting Care of Patients With Heart Failure From AHA 2021
Clinical Thought
Conference Coverage
Congratulations: You achieved a completion on 04/09/2022

Released: December 09, 2021

Expires: December 08, 2022

Telehealth in HF
Telehealth and Heart Failure: New Data From AHA 2021
Clinical Thought
Conference Coverage
Congratulations: You achieved a completion on 04/09/2022

Released: December 13, 2021

Expires: December 12, 2022

Faculty

cover img faculity

Lee R. Goldberg, MD, MPH, FACC

Professor of Medicine
Division of Cardiovascular Medicine
Department of Medicine
Section Chief, Advanced Heart Failure and Cardiac Transplant
University of Pennsylvania
Philadelphia, Pennsylvania

Provided by

ProCE Banner

Supporters

Supported by an educational grant from

Merck

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.